(19)
(11) EP 4 179 320 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
11.09.2024 Bulletin 2024/37

(45) Mention of the grant of the patent:
31.07.2024 Bulletin 2024/31

(21) Application number: 21742115.5

(22) Date of filing: 09.07.2021
(51) International Patent Classification (IPC): 
G01N 33/50(2006.01)
G01N 33/68(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/5008; G01N 33/502; G01N 33/5058; G01N 33/6896; G01N 2800/28; G01N 2800/2821; G01N 2500/00; G01N 2500/10
(86) International application number:
PCT/EP2021/069138
(87) International publication number:
WO 2022/008712 (13.01.2022 Gazette 2022/02)

(54)

SYSTEM

SYSTEM

SYSTÈME


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 10.07.2020 GB 202010620

(43) Date of publication of application:
17.05.2023 Bulletin 2023/20

(73) Proprietor: GTInvent Limited
Aberdeen Scotland AB24 5RP (GB)

(72) Inventors:
  • POLLACK, Saskia, Julie
    Brighton BN1 9QG (GB)
  • MARSHALL, Karen, Elizabeth
    Brighton BN1 9QG (GB)
  • SERPELL, Louise, Charlotte
    Brighton BN1 9QG (GB)
  • WISCHIK, Claude, Michel
    Aberdeen AB24 5RP (GB)
  • HARRINGTON, Charles, Robert
    Aberdeen Aberdeen AB25 2ZD (GB)

(74) Representative: Nick, Amy Sarah et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)


(56) References cited: : 
   
  • CHARLES R. HARRINGTON ET AL: "Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 290, no. 17, 10 March 2015 (2015-03-10), US, pages 10862 - 10875, XP055727618, ISSN: 0021-9258, DOI: 10.1074/jbc.M114.616029
  • AL-HILALY YOUSSRA K ET AL: "Alzheimer's Disease-like Paired Helical Filament Assembly from Truncated Tau Protein Is Independent of Disulfide Crosslinking", JOURNAL OF MOLECULAR BIOLOGY, vol. 429, no. 23, 15 September 2017 (2017-09-15), pages 3650 - 3665, XP085262223, ISSN: 0022-2836, DOI: 10.1016/J.JMB.2017.09.007
  • AL-HILALY YOUSSRA K. ET AL: "Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain", FEBS LETTERS, vol. 594, no. 5, 1 December 2019 (2019-12-01), NL, pages 944 - 950, XP055848181, ISSN: 0014-5793, Retrieved from the Internet <URL:https://onlinelibrary.wiley.com/doi/full-xml/10.1002/1873-3468.13675> DOI: 10.1002/1873-3468.13675
  • POLLACK SASKIA J ET AL: "Paired Helical Filament-Forming Region of Tau (297-391) Influences Endogenous Tau Protein and Accumulates in Acidic Compartments in Human Neuronal Cells", JOURNAL OF MOLECULAR BIOLOGY, ACADEMIC PRESS, UNITED KINGDOM, vol. 432, no. 17, 16 July 2020 (2020-07-16), pages 4891 - 4907, XP086238050, ISSN: 0022-2836, [retrieved on 20200716], DOI: 10.1016/J.JMB.2020.05.027
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).